Interferon alfa-2b (recombinant)

interferon alfa-2b · Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Interferon alfa-2b (recombinant), covering 2014-02-07 to 2014-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A) [Phase 1, Phase 2]

See pricing